NASDAQ:ALLO - Allogene Therapeutics Price Target & Analyst Ratings

Sign in or create an account to add this stock to your watchlist.
$25.79 -0.16 (-0.62 %)
(As of 04/23/2019 01:53 AM ET)
Previous Close$25.95
Today's Range$25.51 - $26.12
52-Week Range$21.67 - $35.55
Volume255,566 shs
Average Volume407,902 shs
Market Capitalization$3.13 billion
P/E RatioN/A
Dividend YieldN/A

Analyst Ratings

Allogene Therapeutics (NASDAQ:ALLO) Price Target and Consensus Rating

  (How are Consensus Ratings Calculated?)
7 Wall Street analysts have issued ratings and price targets for Allogene Therapeutics in the last 12 months. Their average twelve-month price target is $38.20, suggesting that the stock has a possible upside of 48.12%. The high price target for ALLO is $50.00 and the low price target for ALLO is $29.00. There are currently 1 hold rating and 6 buy ratings for the stock, resulting in a consensus rating of "Buy."
Today30 Days Ago90 Days Ago180 Days Ago
Consensus Rating: BuyBuyBuyN/A
Consensus Rating Score: 2.862.832.75N/A
Ratings Breakdown: 0 Sell Rating(s)
1 Hold Rating(s)
6 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
5 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
1 Hold Rating(s)
3 Buy Rating(s)
0 Strong Buy Rating(s)
0 Sell Rating(s)
0 Hold Rating(s)
0 Buy Rating(s)
0 Strong Buy Rating(s)
Consensus Price Target: $38.20$35.25$33.6667N/A
Price Target Upside: 48.12% upside32.87% upside24.69% upsideN/A

Allogene Therapeutics (NASDAQ:ALLO) Consensus Price Target History

Price Target History for Allogene Therapeutics (NASDAQ:ALLO)

Allogene Therapeutics (NASDAQ:ALLO) Analyst Ratings History

DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
4/15/2019William BlairReiterated RatingBuyLowView Rating Details
3/29/2019Piper Jaffray CompaniesInitiated CoverageOverweight ➝ Overweight$50.00HighView Rating Details
3/14/2019Raymond JamesInitiated CoverageOutperform ➝ Outperform$40.00MediumView Rating Details
3/11/2019JPMorgan Chase & Co.Reiterated RatingHold$29.00MediumView Rating Details
3/8/2019CowenReiterated RatingBuyLowView Rating Details
11/5/2018Jefferies Financial GroupInitiated CoverageBuy ➝ Buy$31.00HighView Rating Details
11/5/2018Goldman Sachs GroupInitiated CoverageBuy ➝ Buy$41.00HighView Rating Details
(Data available from 4/23/2017 forward)
This page was last updated on 4/23/2019 by Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with's FREE daily email newsletter.

Yahoo Gemini Pixel